Clover Health Investments Corp Stock Price, News & Analysis

Clover Health (CLOV) has partnered with Thyme Care to enhance oncology care for underserved seniors in New Jersey. This collaboration aims to bridge the gaps in cancer treatment by providing Clover's Medicare Advantage members with personalized support and resources at no cost. Thyme Care's technology will help identify at-risk members and deliver a dedicated care team, which includes physician-guided oncology nurses. Both companies share the mission of improving health equity and patient outcomes while reducing costs associated with cancer care.

Clover Health Investments, Corp. (Nasdaq: CLOV) announced that CEO Vivek Garipalli and President & CTO Andrew Toy will present at the 2021 Wells Fargo Virtual Healthcare Conference on September 9, 2021, at 3:20 p.m. Eastern Time. This presentation aims to highlight Clover Health's commitment to improving health equity for underserved seniors. A live webcast will be available on Clover Health's investor relations website, with an archived replay accessible for 12 months following the event.

For more information, visit Clover Health's investor relations page.

Clover Health Investments announced an extension for holders of its public warrants until September 9, 2021, at 5:00 p.m. NY time. This decision follows a prior announcement that all outstanding public warrants would be redeemed for $0.10 each. Currently, over 90% of the public warrants have been exercised. The warrants can be exercised for fully paid shares at $11.50 each or through a cashless option. Unexercised warrants by the new date will become void, only redeemable at the stated price. Clover Health aims to enhance access to healthcare for seniors.

Clover Health reported a robust total revenue of $412.5 million for Q2 2021, marking a 140% increase year-over-year, driven by the launch of Direct Contracting. Lives under management nearly doubled to 129,000 and the Clover Assistant is projected to manage over $1 billion in annualized revenue. Despite this growth, the company recorded a net loss of $(317.6 million) and a GAAP MA MCR of 111.0%. For full-year 2021, revenue is anticipated between $1.4 billion and $1.5 billion.

Clover Health (Nasdaq: CLOV) has announced the integration of FHIR (Fast Healthcare Interoperability Resources) within the Clover Assistant, enhancing interoperability in healthcare data. This implementation allows Clover Assistant to integrate seamlessly with FHIR-enabled EHRs like athenahealth and Epic, improving personalized healthcare recommendations for seniors. The first new feature is 'Deprescribing,' which helps physicians reduce harmful medications for patients. Clover aims to provide better healthcare access while managing costs effectively, focusing on improving outcomes for underserved seniors.

Clover Health (Nasdaq: CLOV) announced executives will present at KeyBanc's Virtual Technology Leadership Forum on August 12 at 2:00 p.m. ET. The event aims to highlight the company's commitment to improving health equity for underserved seniors in the U.S. A live webcast of the presentation will be available on Clover Health's investor relations website, along with an archived replay post-event. Clover Health’s mission focuses on providing affordable healthcare to seniors who have historically faced barriers in accessing high-quality care.

Clover Health (CLOV) has partnered with ValueH to enhance provider growth in Florida's ACO network. This strategic alliance will facilitate the integration of providers onto the Clover Assistant Platform, aimed at improving care for fee-for-service Medicare beneficiaries. Clover's Direct Contracting Entity, launching in 2022, will allow providers to use the Clover Assistant for managing Original Medicare patients and streamline reimbursement processes. As of April 2021, Clover has engaged around 1,800 individual providers and serviced over 65,000 beneficiaries.

Clover Health (Nasdaq: CLOV) has sponsored the 2021 Quality Innovation Series, organized by the National Committee for Quality Assurance (NCQA). The series promotes healthcare quality and equity, featuring industry leaders sharing best practices. Clover was recognized by CMS’ Office of Minority Health for demonstrating high performance in the Medicare Advantage Health Equity Summary Score (HESS). With a mission to improve healthcare access for underserved seniors, Clover uses its Clover Assistant technology to enhance care and reduce costs, emphasizing equitable healthcare delivery.

Clover Health (Nasdaq: CLOV) will redeem all outstanding Public and Private Warrants at a redemption price of $0.10 per warrant. This redemption applies to warrants issued during the IPO and is contingent on the Common Stock's Reference Value being below $18.00. The redemption date is set for August 23, 2021, and warrants unexercised by 5:00 p.m. New York City time will be void. Holders can exercise their warrants until the redemption date. The company has registered shares underlying warrants with the SEC.